'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.'
United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is unknown, according to court papers being quoted in the UK media.
Despite these rare occurrences, the pharmaceutical company maintains that extensive clinical trial data and real-world evidence consistently support the vaccine's safety and efficacy.
'The Bhashini Mission has delivered a working technology at large scale, which is as good as or better than the one with MNC tech giants.'
The world is learning about a side effect of the COVID vaccine called Thrombosis with Thrombocytopenia Syndrome, he said.
But no extra risk after second dose, shows study led and funded by drug maker, reports Sohini Das.
Domestic air passenger traffic was back to the growth trajectory in June amid the falling number of COVID-19 cases in the country with around three million passengers flying on local routes in the previous month as against around two million in May, a report said on Tuesday. Though there is some recovery observed in June, stress on demand continues, driven largely by the second wave of the pandemic, limiting travel to only necessary travel, credit rating agency ICRA said in its report. On a sequential basis, domestic passenger traffic was up 41-42 per cent in June over May.
'Hear2Read' -- an open-source Text To Speech (TTS) software that offers audio books in Gujarati, Kannada, Marathi, Punjabi, Tamil and Telugu -- is a first of its kind initiative in the country.
A Lucknow-based software company has developed the first Indian language Text-To-Speech software to enable differently-abled people to pursue their education.
Awfis stands out for its 'ambience' and 'ease of doing business'.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances